HR Execs on the Move

NeoChord

www.neochord.com

 
NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2- to 3-inch incision between the ribs in patients with severe mitral valve regurgitation (MR). In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) that involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on cardio-pulmonary bypass (CPB).
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
David Chung
 President and Chief Executive Officer Profile

Similar Companies

Regional Medical Laboratories

Regional Medical Laboratories is a Battle Creek, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Clean Concepts

Clean Concepts is a Lancaster, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Choice Network

Health Choice Network (HCN) is a national model of a successful collaboration of community health centers (CHCs) and one of several HRSA-sponsored Health Center Controlled Networks. HCN is addressing health care disparities, providing health information technologies and strengthening the financial position of the community health care system. Founded in 1994 as a 501c(3) organization, HCN was created and is governed by its members who comprise a minority-based Board of Directors. Network members maintain their vital community orientation by retaining their local-governing, consumer-majority Boards of Directors. Community Health Centers that own and control the Network operate more efficiently, can deliver care more effectively and are working together to care for more patients.

Highland Park Healthcare Inc

Highland Park Healthcare Inc is a Highland Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genetics Squared

Genetics Squared is a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence and proprietary point-of-care equipment for the evaluation and management of cardiovascular disease.